DCAF12

DCAF12 is the substrate receptor of the CRL4^DCAF12 E3 ubiquitin ligase complex, recognizing C-terminal di-glutamate degrons on substrates to direct their ubiquitination for proteasomal degradation or non-degradative modification. Cryo-EM structures of DDB1–DCAF12 bound to CCT5 and MAGE-A3 reveal a positively charged pocket at the center of its WD40 β-propeller that captures the di-Glu degron with nanomolar affinity, and DCAF12 selectively ubiquitinates unassembled monomeric subunits (e.g., CCT5, MCMBP) rather than their fully assembled complexes (TRiC, MCM2-7), establishing it as a key Assembly Quality Control ligase that also controls starvation-induced autophagy via MAGE-A3/6 degradation, DNA replication licensing via MCMBP turnover, spermatogenesis, and T cell homeostasis via MOV10 degradation (PMID:36715408, PMID:38665159, PMID:31267705, PMID:34065512, PMID:41145411). DCAF12 also promotes apoptosis independently of its degron-recognition function by binding IAP family members (XIAP, cIAP1, cIAP2) through their BIR domains and antagonizing their caspase-inhibitory activity, a role conserved in Drosophila where DCAF12 is required for RHG-mediated apoptosis and Diap1 cleavage (PMID:35459779, PMID:26972874). Additionally, CRL4^DCAF12 catalyzes non-degradative ubiquitination of TRiC/CCT subunits to enhance chaperonin-assisted folding of cytoskeletal and signaling clients, promoting YAP, STAT3, and mTOR pathway activation in cancer contexts (PMID:41047465).

1. 2016 Medium

   Whether DCAF12 had a biological role beyond being a DDB1-associated factor was unknown; genetic studies in Drosophila established that DCAF12 is necessary and sufficient for RHG-mediated apoptosis through Diap1 cleavage, linking it to IAP antagonism and tumor suppression.

   Evidence Drosophila loss-of-function genetics with apoptosis and tumor suppressor epistasis

   PMID:26972874

   Open questions at the time

   • No biochemical reconstitution of DCAF12–Diap1 interaction
   • Mechanism of Diap1 cleavage promotion not resolved
   • Not confirmed in mammalian system at this stage
2. 2019 High

   Two studies simultaneously revealed CRL4^DCAF12's substrate-targeting and synaptic roles: proteomic identification showed DCAF12 recruits MAGE-A3/6 for proteasomal degradation to enable starvation-induced autophagy, while Drosophila studies demonstrated presynaptic regulation of neurotransmitter release and postsynaptic Cul4-dependent ubiquitination of glutamate receptors.

   Evidence Proteomic interactome with proteasome inhibitor rescue and autophagy assays in human cells; Drosophila electrophysiology and genetic epistasis with Cul4

   PMID:30670470 PMID:31267705

   Open questions at the time

   • Degron motif on MAGE-A3/6 not yet identified
   • Glutamate receptor substrates not shown to be direct DCAF12 substrates biochemically
   • No structural insight into substrate recognition
3. 2021 High

   The physiological importance of DCAF12 in mammals was established by knockout mice, revealing MOV10 as a C-terminal acidic degron-bearing substrate whose stabilization causes impaired spermatogenesis and aberrant caspase activation in T cells.

   Evidence Dcaf12 knockout mice with sperm counts, meiotic markers, flow cytometry for caspase activation, and degron mutant analysis

   PMID:34065512

   Open questions at the time

   • Precise degron sequence on MOV10 not structurally resolved
   • Whether spermatogenesis defect is MOV10-dependent or involves additional substrates unclear
   • Mechanism linking MOV10 to caspase activation in T cells not fully dissected
4. 2022 Medium

   The apoptotic function of DCAF12 was extended to human cells by demonstrating that DCAF12 translocates from nucleus to cytoplasm upon apoptotic stimuli and directly binds BIR domains of multiple IAPs (XIAP, cIAP1, cIAP2, BRUCE) to block caspase inhibition and suppress NF-κB signaling.

   Evidence Reciprocal co-immunoprecipitation, subcellular fractionation, caspase and NF-κB reporter assays with domain mapping

   PMID:35459779

   Open questions at the time

   • Single lab study; independent replication needed
   • Whether IAP binding is independent of or coupled to CRL4 ligase activity not resolved
   • In vivo relevance of nuclear-to-cytoplasmic translocation not tested in animal models
5. 2023 High

   The structural basis for substrate recognition was resolved: a 2.8 Å cryo-EM structure of DDB1–DCAF12–CCT5 showed that DCAF12's WD40 β-propeller uses a central positively charged pocket to capture the C-terminal di-Glu degron, and DCAF12 ubiquitinates only monomeric CCT5, not TRiC-assembled CCT5, establishing the Assembly Quality Control paradigm.

   Evidence Cryo-EM at 2.8 Å, mutagenesis of degron-binding pocket, in vitro ubiquitination comparing monomeric vs. assembled CCT5

   PMID:36715408

   Open questions at the time

   • How assembly state is sensed (steric occlusion vs. allosteric mechanism) not fully elucidated
   • Scope of the di-Glu degron proteome not systematically defined
   • No in vivo validation of assembly quality control function at this stage
6. 2024 High

   A second cryo-EM structure (DDB1–DCAF12–MAGEA3 at 3.17 Å) confirmed the generality of di-Glu degron recognition and biophysical assays demonstrated nanomolar affinity, validating the degron-binding pocket as a conserved substrate recruitment mechanism.

   Evidence Cryo-EM structure, NanoBRET, ITC/SPR with degron peptide mutagenesis

   PMID:38665159

   Open questions at the time

   • Whether DCAF12 recognizes non-di-Glu acidic degrons remains untested
   • Structural basis for IAP (BIR domain) binding by DCAF12 not resolved
   • Therapeutic tractability of the degron pocket not explored
7. 2025 High

   Two studies extended DCAF12 substrate repertoire and functional impact: CRL4^DCAF12 degrades MCMBP to enable MCM2-7 helicase assembly and proper replication licensing, and separately catalyzes non-degradative ubiquitination of TRiC subunits to enhance chaperonin activity and promote oncogenic signaling (YAP, STAT3, mTOR) in lung cancer metastasis.

   Evidence Genetic knockdown/knockout with chromatin fractionation and DNA fiber assays (MCMBP); in vitro ubiquitination, proteomics, and xenograft metastasis models (TRiC)

   PMID:41047465 PMID:41145411

   Open questions at the time

   • Non-degradative ubiquitination of TRiC requires independent validation
   • Whether MCMBP degradation also involves di-Glu degron recognition not structurally confirmed
   • Relative contributions of degradative vs. non-degradative ubiquitination to TRiC regulation unclear

• Key open questions include the full scope of the di-Glu degron proteome, the structural basis for DCAF12's IAP/BIR-domain interaction, whether assembly quality control extends to additional multisubunit complexes beyond TRiC and MCM2-7, and whether DCAF12's ligase-dependent and ligase-independent (IAP-antagonist) functions are coordinated.
• Systematic identification of all C-terminal di-Glu degron substrates not performed
• No structure of DCAF12 bound to any IAP BIR domain
• Relationship between CRL4 ligase activity and IAP-antagonist function unresolved